Canaccord lowered the firm’s price target on Edgewell Personal Care (EPC) to $32 from $35 and keeps a Buy rating on the shares. The firm said they reported a Q3 miss but as they head into Q4 management expects organic sales to return to growth due to strength in their “Right to Win” portfolio and expectations to grow international.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care: Hold Rating Amidst Valuation Challenges and Future Growth Pressures
- Edgewell upgraded to Equal Weight from Underweight at Morgan Stanley
- Edgewell Personal Care Reports Q3 2025 Earnings
- Edgewell Personal Care Co Faces Challenges Amid Growth
- Edgewell Personal Care reports Q3 adjusted EPS 92c, consensus 99c